Jing Ai

3.5k total citations
128 papers, 2.8k citations indexed

About

Jing Ai is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Jing Ai has authored 128 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 38 papers in Oncology and 31 papers in Hepatology. Recurrent topics in Jing Ai's work include Liver physiology and pathology (31 papers), Fibroblast Growth Factor Research (21 papers) and PI3K/AKT/mTOR signaling in cancer (16 papers). Jing Ai is often cited by papers focused on Liver physiology and pathology (31 papers), Fibroblast Growth Factor Research (21 papers) and PI3K/AKT/mTOR signaling in cancer (16 papers). Jing Ai collaborates with scholars based in China, United States and Mongolia. Jing Ai's co-authors include Meiyu Geng, Hong‐Rui Tian, Zhong‐Ming Sun, Chao‐Ying Gao, Yinchun Ji, Peng Xia, Jian Ding, Ao Zhang, Wenhu Duan and Peng Xia and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Jing Ai

121 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Ai China 30 1.2k 845 528 464 415 128 2.8k
Miki Murata Japan 31 1.3k 1.1× 3.5k 4.1× 504 1.0× 402 0.9× 490 1.2× 97 5.2k
Wei Lü China 37 2.2k 1.8× 1.3k 1.6× 139 0.3× 462 1.0× 516 1.2× 239 4.6k
Patric J. Jansson Australia 42 2.6k 2.1× 981 1.2× 417 0.8× 320 0.7× 2.4k 5.7× 85 5.5k
Xiaoxing Wu China 26 547 0.4× 834 1.0× 154 0.3× 201 0.4× 186 0.4× 71 2.2k
Tsuyoshi Miura Japan 33 1.2k 0.9× 2.7k 3.2× 512 1.0× 256 0.6× 159 0.4× 233 4.3k
Pranav Gupta United States 29 1.8k 1.5× 702 0.8× 128 0.2× 337 0.7× 2.1k 5.2× 77 3.9k
Shaloam Dasari United States 8 2.0k 1.6× 798 0.9× 179 0.3× 440 0.9× 1.7k 4.2× 12 4.8k
Tuanjie Li China 34 476 0.4× 2.6k 3.1× 287 0.5× 127 0.3× 509 1.2× 154 4.0k
Shaohua Gou China 31 663 0.5× 1.2k 1.4× 249 0.5× 430 0.9× 1.2k 2.9× 115 2.3k
Ming-Hua Hsu Taiwan 22 494 0.4× 354 0.4× 404 0.8× 525 1.1× 333 0.8× 57 2.0k

Countries citing papers authored by Jing Ai

Since Specialization
Citations

This map shows the geographic impact of Jing Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ai more than expected).

Fields of papers citing papers by Jing Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ai. The network helps show where Jing Ai may publish in the future.

Co-authorship network of co-authors of Jing Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ai. A scholar is included among the top collaborators of Jing Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ai. Jing Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Jian, Yiwei Zhang, Chao Wang, et al.. (2025). Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads. Journal of the American Chemical Society. 147(18). 15469–15481. 14 indexed citations
2.
Zhang, Yunong, Peng Xia, Jian Zou, et al.. (2022). Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors. Journal of Medicinal Chemistry. 65(22). 15374–15390. 15 indexed citations
3.
Xia, Peng, Yinchun Ji, Yang Dai, et al.. (2021). The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation. Molecular Cancer Therapeutics. 20(11). 2198–2206. 9 indexed citations
4.
Ai, Jing, Sheng-Qun Chen, Feng Chen, et al.. (2020). <p>Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas</p>. Cancer Management and Research. Volume 12. 3023–3031. 1 indexed citations
5.
Wu, Xiaowei, Rongrong Cui, Yulan Wang, et al.. (2020). Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors. Acta Pharmaceutica Sinica B. 11(3). 781–794. 26 indexed citations
6.
Wang, Xinyi, Jing Ai, Hongyan Liu, et al.. (2018). The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. Molecular Cancer Therapeutics. 18(3). 667–679. 11 indexed citations
7.
Ai, Jing, Yi Chen, Peng Xia, et al.. (2017). Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. Molecular Cancer Therapeutics. 17(4). 751–762. 26 indexed citations
8.
Liu, Hongyan, Jing Ai, Aijun Shen, et al.. (2016). c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors. Clinical Cancer Research. 23(4). 974–984. 28 indexed citations
9.
Song, Zilan, Yinchun Ji, Xing Li, et al.. (2016). An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core. European Journal of Medicinal Chemistry. 118. 244–249. 12 indexed citations
10.
Gao, Chao‐Ying, Hong‐Rui Tian, Jing Ai, et al.. (2016). A microporous Cu-MOF with optimized open metal sites and pore spaces for high gas storage and active chemical fixation of CO2. Chemical Communications. 52(74). 11147–11150. 132 indexed citations
11.
Jiang, Xiaolong, Ji Zhou, Jing Ai, et al.. (2015). Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study. European Journal of Medicinal Chemistry. 105. 39–56. 15 indexed citations
12.
Jiang, Xiaolong, Hongyan Liu, Zilan Song, et al.. (2014). Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold. Bioorganic & Medicinal Chemistry. 23(3). 564–578. 15 indexed citations
13.
Liu, Zhiqing, Jing Ai, Peng Xia, et al.. (2014). Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities. ACS Medicinal Chemistry Letters. 5(4). 304–308. 27 indexed citations
14.
Wang, Lu, Jing Ai, Yanyan Shen, et al.. (2014). SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo. Cancer Letters. 351(1). 143–150. 12 indexed citations
15.
Zhang, Wei, Jing Ai, Peng Xia, et al.. (2014). Discovery of novel type II c-Met inhibitors based on BMS-777607. European Journal of Medicinal Chemistry. 80. 254–266. 25 indexed citations
16.
Ai, Jing, Yi Chen, Haotian Zhang, et al.. (2013). Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells. Acta Pharmacologica Sinica. 35(1). 89–97. 15 indexed citations
17.
Gao, Huquan, Weizhong Liu, Tianjiao Zhu, et al.. (2012). Diketopiperazine alkaloids from a mangrove rhizosphere soil derived fungus Aspergillus effuses H1-1. Organic & Biomolecular Chemistry. 10(47). 9501–9501. 59 indexed citations
18.
Zhang, Dengyou, Jing Ai, Zhongjie Liang, et al.. (2012). Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry. 20(17). 5169–5180. 27 indexed citations
19.
Chen, Danqi, Ying Wang, Yuchi Ma, et al.. (2012). Discovery of 3H‐Imidazo[4,5‐b]pyridines as Potent c‐Met Kinase Inhibitors: Design, Synthesis, and Biological Evaluation. ChemMedChem. 7(6). 1057–1070. 11 indexed citations
20.
Ai, Jing, Qingjuan Tang, Yanlin Wu, et al.. (2011). The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute. 103(22). 1696–1712. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miki Murata Breakdown of academic impact, for papers by Wei Lü Breakdown of academic impact, for papers by Patric J. Jansson Breakdown of academic impact, for papers by Xiaoxing Wu Breakdown of academic impact, for papers by Tsuyoshi Miura Breakdown of academic impact, for papers by Pranav Gupta Breakdown of academic impact, for papers by Shaloam Dasari Breakdown of academic impact, for papers by Tuanjie Li Breakdown of academic impact, for papers by Shaohua Gou Breakdown of academic impact, for papers by Ming-Hua Hsu
Rankless by CCL
2026